JPS5557589A - 33alkylqithantine compoumd - Google Patents

33alkylqithantine compoumd

Info

Publication number
JPS5557589A
JPS5557589A JP13584579A JP13584579A JPS5557589A JP S5557589 A JPS5557589 A JP S5557589A JP 13584579 A JP13584579 A JP 13584579A JP 13584579 A JP13584579 A JP 13584579A JP S5557589 A JPS5557589 A JP S5557589A
Authority
JP
Japan
Prior art keywords
methylbutyl
compound
formula
produced
aminouracil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13584579A
Other languages
English (en)
Other versions
JPH0130834B2 (ja
Inventor
Gunnaa Chierin Peru
Geran Augusuto Peruson Kaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco AB filed Critical Draco AB
Publication of JPS5557589A publication Critical patent/JPS5557589A/ja
Publication of JPH0130834B2 publication Critical patent/JPH0130834B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP13584579A 1978-10-20 1979-10-19 33alkylqithantine compoumd Granted JPS5557589A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7810947A SE7810947L (sv) 1978-10-20 1978-10-20 3-alkylxanthines

Publications (2)

Publication Number Publication Date
JPS5557589A true JPS5557589A (en) 1980-04-28
JPH0130834B2 JPH0130834B2 (ja) 1989-06-22

Family

ID=20336145

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13584579A Granted JPS5557589A (en) 1978-10-20 1979-10-19 33alkylqithantine compoumd

Country Status (24)

Country Link
US (2) US4548818A (ja)
EP (1) EP0010531B1 (ja)
JP (1) JPS5557589A (ja)
AT (1) ATE1145T1 (ja)
AU (1) AU530717B2 (ja)
CA (1) CA1131632A (ja)
DD (1) DD146708A5 (ja)
DE (1) DE2963021D1 (ja)
DK (1) DK148884C (ja)
ES (1) ES485178A1 (ja)
FI (1) FI66867C (ja)
GR (1) GR72945B (ja)
HK (1) HK7785A (ja)
HU (1) HU180220B (ja)
IE (1) IE49184B1 (ja)
NO (1) NO152561C (ja)
NZ (1) NZ191870A (ja)
PH (1) PH16676A (ja)
PL (1) PL119413B1 (ja)
PT (1) PT70350A (ja)
SE (1) SE7810947L (ja)
SG (1) SG86084G (ja)
SU (1) SU952105A3 (ja)
ZA (1) ZA795113B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56169690A (en) * 1980-05-02 1981-12-26 Nestle Sa Xanthinederivative and manufacture

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
IT1200944B (it) * 1982-08-10 1989-01-27 Malesci Sas Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico
US5338741A (en) * 1986-10-27 1994-08-16 Nestec S.A. 1-hydroxyalkylxanthines and medicaments containing them
US5246931A (en) * 1988-10-25 1993-09-21 Bristol-Myers Squibb Company Carbocyclic nucleoside analogs
IL92096A0 (en) 1988-10-25 1990-07-12 Abbott Lab Carboxylic nucleoside analogs
US5153352A (en) * 1988-10-25 1992-10-06 Bristol-Myers Squibb Company Process for preparation of intermediates of carbocyclic nucleoside analogs
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
US4988703A (en) * 1989-05-22 1991-01-29 Abbott Laboratories Carbocyclic nucleoside analogs with antiviral activity
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
ES2139588T3 (es) * 1991-03-05 2000-02-16 Ajinomoto Kk Derivado de ciclopropano.
US5877179A (en) * 1992-09-29 1999-03-02 The United States Of America As Represented By The Department Of Health And Human Services Xanthines for identifying CFTR--binding compounds useful for activating chloride conductance in animal cells
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
US5786360A (en) * 1996-11-19 1998-07-28 Link Technology Incorporated A1 adenosine receptor antagonists
US6376521B1 (en) 1998-07-10 2002-04-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services A3 adenosine receptor antagonists
WO2001051490A1 (en) * 2000-01-14 2001-07-19 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methanocarba cycloalkyl nucleoside analogues
US6623553B2 (en) * 2001-04-20 2003-09-23 John Russell Printing process with edible inks
AR039385A1 (es) 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
CA2516250A1 (en) 2003-02-19 2004-09-02 Endacea, Inc. A1 adenosine receptor antagonists
WO2005009343A2 (en) * 2003-06-06 2005-02-03 Endacea, Inc. A1 adenosine receptor antogonists
JP2007506804A (ja) * 2003-06-09 2007-03-22 エンダセア， インコーポレイテッド Ａ１アデノシンレセプターアンタゴニスト
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
DE102006020519A1 (de) * 2006-05-03 2007-11-08 Robert Bosch Gmbh Vorrichtung zum Einfalten zumindest einer Lasche einer Verpackung
TW200804383A (en) 2006-06-05 2008-01-16 Astrazeneca Ab New compounds
US7743683B2 (en) * 2006-08-15 2010-06-29 Umagination Labs, L.P. Systems and methods of a power tool system with interchangeable functional attachments powered by a direct rotational drive
WO2011068978A1 (en) 2009-12-02 2011-06-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives and dendrimer conjugates thereof
US11225481B2 (en) * 2015-12-29 2022-01-18 Centre National De La Recherche Scientifique Xanthine derivative inhibitors of BET proteins

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5125009U (ja) * 1974-08-14 1976-02-24
JPS52133295U (ja) * 1976-04-05 1977-10-11
JPS5345102U (ja) * 1976-09-20 1978-04-18

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1245969B (de) * 1967-08-03 VEB Arzneimittelwerk Dresden, Radebeul Verfahren zur Herstellung von Xanthinderivaten
DE864868C (de) * 1943-10-02 1953-01-29 Hellmut Dr Bredereck Verfahren zur Herstellung von Purinverbindungen
US2646432A (en) * 1947-01-13 1953-07-21 Mallinckrodt Chemical Works Method of preparing 2, 6-diketopurines
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
GB683523A (en) * 1948-08-18 1952-12-03 Beecham Res Lab The manufacture of purine derivatives
US2781344A (en) * 1953-05-04 1957-02-12 Monsanto Chemicals Formylation of amino-pyrimidines
US2844576A (en) * 1955-11-22 1958-07-22 American Cyanamid Co Preparation of purines
BE592753A (ja) * 1959-07-09 1900-01-01
GB982079A (en) * 1962-05-01 1965-02-03 Dresden Arzneimittel Process for the production of xanthine derivatives
GB1008454A (en) * 1963-03-26 1965-10-27 Dresden Arzneimittel Pseudoxanthines
JPS53890B2 (ja) * 1972-04-22 1978-01-12
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
FR2346244A1 (fr) * 1976-03-30 1977-10-28 Chamagne Pierre Nouveau conditionnement pour la conservation de liquides alimentaires
US4089959A (en) * 1976-03-31 1978-05-16 Cooper Laboratories, Inc. Long-acting xanthine bronchodilators and antiallergy agents
CA1077932A (en) * 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
US4338319A (en) * 1979-11-27 1982-07-06 Aktiebolaget Draco Method for the treatment of chronic obstructive airway or cardiac diseases
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5125009U (ja) * 1974-08-14 1976-02-24
JPS52133295U (ja) * 1976-04-05 1977-10-11
JPS5345102U (ja) * 1976-09-20 1978-04-18

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56169690A (en) * 1980-05-02 1981-12-26 Nestle Sa Xanthinederivative and manufacture

Also Published As

Publication number Publication date
PL219065A1 (ja) 1980-06-16
SE7810947L (sv) 1980-04-21
NO793377L (no) 1980-04-22
IE791987L (en) 1980-04-20
FI793224A (fi) 1980-04-21
DK148884B (da) 1985-11-04
CA1131632A (en) 1982-09-14
HU180220B (en) 1983-02-28
ATE1145T1 (de) 1982-06-15
EP0010531B1 (en) 1982-06-02
DD146708A5 (de) 1981-02-25
SU952105A3 (ru) 1982-08-15
PL119413B1 (en) 1981-12-31
PH16676A (en) 1983-12-13
NO152561B (no) 1985-07-08
ZA795113B (en) 1980-10-29
HK7785A (en) 1985-02-08
US4548818A (en) 1985-10-22
SG86084G (en) 1985-06-07
DK432179A (da) 1980-04-21
GR72945B (ja) 1984-01-17
AU530717B2 (en) 1983-07-28
NZ191870A (en) 1984-07-06
US4644001A (en) 1987-02-17
JPH0130834B2 (ja) 1989-06-22
AU5187179A (en) 1980-05-01
FI66867C (fi) 1984-12-10
PT70350A (en) 1979-11-01
DE2963021D1 (en) 1982-07-22
ES485178A1 (es) 1980-05-16
IE49184B1 (en) 1985-08-21
DK148884C (da) 1986-04-07
EP0010531A1 (en) 1980-04-30
FI66867B (fi) 1984-08-31
NO152561C (no) 1985-10-16

Similar Documents

Publication Publication Date Title
JPS5557589A (en) 33alkylqithantine compoumd
HUT50820A (en) Process for producing purine derivatives with antiviral effect
GB1530912A (en) Compositions containing 9-(2-hydroxy-3-alkyl)-adenines
IE32844L (en) Hydrazino-benzocinnoline and -benzocycloheptapyridazine¹derivatives
Stephen et al. 849. Syntheses in the quinazolone series. Part IV. The conversion of N-aroylorthanilamides into 2-arylquinazol-4-ones
GB1467740A (en) Derivatives of inbutylamine and processes for preparing the same
GB1562811A (en) Reduction process for the preparation of 4-(hydroxymethyl)-imidazoles
JPH0549666B2 (ja)
EP0569587A4 (ja)
OWEN et al. Studies on the Chemistry of Heterocyclics. X. Syntheses of Thenal-and Thenyl-Barbituric Acids
JPS5513215A (en) Preparation of 1-(5-oxohexyl)-3,7-dimethylxanthine
CA1075691A (en) Xanthine derivatives
JPS5492989A (en) Preparation of substituted theobromine
JPS5513216A (en) Preparation of 1-(5-oxohexyl)-3,7-dimethylxanthine
CA1075693A (en) Xanthine derivatives
IE42462L (en) 1-methyl-2-nitroimidazole-5-methanol derivatives
GB1503476A (en) Process for the preparation of 6-methylpterin
Dvornik et al. Preparation of Some lmino-and Cyano-imino-substituted Barbiturates
JPS5651481A (en) 6-cyano-2-oxo-3-methyl-2,3-dihydropurine
JPS55104283A (en) Preparation of 1-(5'-oxyhexyl)-3,7-dimethylxanthine
JPS5576877A (en) Preparation of 1-(5-oxohexyl)-3,7-dialkylxanthine
JPS55118486A (en) Preparation of xanthine derivative
GR3026373T3 (en) PROCESS FOR PRODUCING -g(a)-ALKOXYIMINOPHENYLACETONITRILE DERIVATIVE.
FR2388800A1 (fr) Procede de preparation de 4,6-diamino-5-arylazopyrimidine
NL7704515A (en) 4,6-Di:amino-5-arylazo-pyrimidine(s) prepn. - from aryl-azo-malononitrile for hydrogenation to adenine